Gene · 4005
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complexity and Challenges of Translating the Dark Zone Signature Into Immunohistochemistry in Diffuse Large B-Cell Lymphoma. | Mod Pathol | 2026 | 41747827 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Childhood-Onset Celiac Disease Autoimmunity and Risk of Depression and Anxiety across the Lifespan: A Longitudinal Analysis of a Large Real-World Cohort. | Digestion | 2026 | 41712501 | PubTator, text mining | PubMed |
| GATA1 Drives Human Erythropoiesis via Liquid-Liquid Phase Separation. | FASEB J | 2026 | 41693617 | PubTator, text mining | PubMed |
| LDB1 represses fetal hemoglobin expression by enhancing BCL11A transcription. | Redox Biol | 2026 | 41650821 | PubTator, text mining | PubMed |
| Cytoplasmic LIM domain only 2 enhances tumor endothelial cell migration through integrin β1-mediated focal adhesion signaling. | Acta Neuropathol Commun | 2026 | 41639897 | PubTator, text mining | PubMed |
| Seismic response analysis of coal mine shaft tower structure considering PSSI effect under different sites. | Sci Rep | 2026 | 41617869 | PubTator, text mining | PubMed |
| The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemia. | Blood Neoplasia | 2026 | 41608320 | PubTator, text mining | PubMed |
| Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response. | Hum Pathol | 2026 | 41581705 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Diagnostic clues in patients with clinical malabsorption and pathological small intestinal villous atrophy: Immune-mediated type and beyond. | World J Gastroenterol | 2026 | 41551832 | PubTator, text mining | PubMed |
| Comment on "LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of clear cell renal cell carcinoma". | Transl Oncol | 2026 | 41172876 | PubTator, text mining | PubMed |
| Development and validation of a heme metabolism-related genes signature for diagnosis and immunological characterization of lupus nephritis. | Clin Chim Acta | 2026 | 40976321 | PubTator, text mining | PubMed |
| PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemia. | Haematologica | 2026 | 40637766 | PubTator, text mining | PubMed |
| Validation of a rapid test for celiac disease detection in first-degree relatives - A prospective study. | Rev Esp Enferm Dig | 2026 | 39508123 | PubTator, text mining | PubMed |
| Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis. | Elife | 2025 | 41385269 | PubTator, text mining | PubMed |
| Methodological landscape in the field of integration site identification of retroviruses and retroviral vectors. | Front Bioeng Biotechnol | 2025 | 41306907 | PubTator, text mining | PubMed |
| Detection of Gliadin-Activated CD4+ T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease. | J Cell Mol Med | 2025 | 41121990 | PubTator, text mining | PubMed |
| Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use. | Mol Biol Rep | 2025 | 40965810 | PubTator, text mining | PubMed |
| Dissecting cross-lineage tumourigenesis under p53 inactivation through single-cell multi-omics and spatial transcriptomics. | Clin Transl Med | 2025 | 40887856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4005/papers?page=2